Cider Sante, the French pharmaceutical services company, has signed an accord with Medco, the US health spending management group acquired by Merck & Co, to introduce a system of computer-assisted drug prescribing into France.
Despite the French addiction to modern computer technology, it remains largely unknown to French doctors. Cider has negotiated a long-term exclusive license from Medco and intends to create a new subsidiary to run the operation. Designated Coordination Medicale et Pharmaceutique (CMP), its equity capital will be open to doctors' organizations such as MG France. Medco may also acquire a stake in CMP at a later stage.
The immediate task of the new group will be to set up a network of general practitioners in a number of test regions. Currently, scarcely one doctor in 10 has a computer, and those who have use them for secretarial and accounting purposes only. Cider says it hopes to connect 20,000-30,000 doctors within four years.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze